BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioCon Limited 

20th KM Hosur Road

Electronics City  Bangalore  560 100  India
Phone: 90-80-2808-2808 Fax: 91-80-2852-3423


SEARCH JOBS




Industry
Biotechnology






 Company News
BioCon Limited (BIOCON.NS) Collaborates With Advaxis, Inc. For "ADXS-HPV" A Novel Cancer Immunotherapy 1/22/2014 8:37:53 AM    More...
BioCon Limited (BIOCON.NS) Hits Roche (RHHBY) First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin 1/20/2014 8:08:38 AM    More...
Mylan Inc. (MYL)-BioCon Limited (BIOCON.NS) Receive First Indian Biosimilar Regulatory Approval For Herceptin® 11/26/2013 7:27:51 AM    More...
BioCon Limited (BIOCON.NS) Partners With CytoSorbents, Inc. to Market CytoSorb® - A "First-in-Class" Therapy for Sepsis Management 9/16/2013 7:51:28 AM    More...
Mylan Inc. (MYL) Ties Up With BioCon Limited (BIOCON.NS) for Insulin Marketing 2/14/2013 8:37:59 AM    More...
BioCon Limited (BIOCON.NS), Bristol-Myers Squibb Company (BMY) Sign Pact for Experimental Oral Insulin Drug 11/16/2012 7:46:49 AM    More...
BioCon Limited (BIOCON.NS) to Sell 7.69% of Research Unit to GE Capital for $23 Million 10/31/2012 8:03:04 AM    More...
BioCon Limited (BIOCON.NS) Close to Oral Insulin Deal With Bristol-Myers Squibb Company (BMY) 7/27/2012 7:41:31 AM    More...
BioCon Limited (BIOCON.NS) Opens Biologics Research Center; Will Hire 300 Scientists 4/6/2012 7:25:21 AM    More...
BioCon Limited (BIOCON.NS) Plunges After Pfizer Inc. (PFE) Scraps $350 Million Insulin Pact 3/13/2012 6:27:04 AM    More...
123